Form D · Other Health Care
Sterigenics-Nordion Topco Parent, LLC
New York, NY · CIK 0001643514
Offering snapshot reported May 29, 2015 · SEC filing
- Reported sold
- $26M Offering amount: $26M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 15, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 29, 2015 | Initial | $25,990,000 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240823
Source: Form D, filed May 29, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean L. Cunningham | Director |
| Timothy J. Curt | Executive |
| David A. Donnini | Director |
| Stephanie S. Geveda | Director |
| Steven G. Glenn | Executive |
| Noah Knauf | Director, Executive |
| Robert B. Knauss | Executive |
| Constantine S. Mihas | Director |
| Michael Mulhern | Director |
| James C. Neary | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Warburg Pincus Llc 450 Lexington Avenue
New York, NY, 10017
New York, NY, 10017